166 phenotypes from 10 alleles in 13 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Klecalc1/Klecalc1 involves: C3H/HeH * C57BL/6J	abnormal aorta wall morphology	J:229255
	abnormal circulating protein level	J:229255
	abnormal femur morphology	J:229255
	abnormal incus morphology	J:229255
	abnormal long bone epiphyseal plate proliferative zone	J:229255
	abnormal malleus manubrium morphology	J:229255
	abnormal malleus morphology	J:229255
	abnormal middle ear ossicle morphology	J:229255
	abnormal rib morphology	J:229255
	abnormal vertebrae morphology	J:229255
	absent pinna reflex	J:229255
	calcified aorta	J:229255
	calcified pulmonary alveolus	J:229255
	calcified skin	J:229255
	calcinosis	J:229255
	decreased body size	J:229255
	decreased bone mineral content	J:229255
	decreased bone mineral density of femur	J:229255
	decreased circulating glucose level	J:229255
	decreased circulating serum albumin level	J:229255
	decreased femur compact bone thickness	J:229255
	decreased long bone epiphyseal plate size	J:229255
	decreased subcutaneous adipose tissue amount	J:229255
	decreased width of hypertrophic chondrocyte zone	J:229255
	emphysema	J:229255
	hunched posture	J:229255
	impaired hearing	J:229255
	increased alkaline phosphatase activity	J:229255
	increased circulating phosphate level	J:229255
	increased vitamin D level	J:229255
	kyphoscoliosis	J:229255
	lung inflammation	J:229255
	nephrocalcinosis	J:229255
	postnatal growth retardation	J:229255
	premature death	J:229255
	renal necrosis	J:229255
	short femur	J:229255
	short malleus	J:229255
	short malleus manubrium	J:229255
	skin atrophy	J:229255
	small stapes obturator foramen	J:229255
	thick zygomatic arch	J:229255
	thin epidermis	J:229255
	wide ribs	J:229255
Klecalc2/Klecalc2 involves: C3H/HeH * C57BL/6J	abnormal femur morphology	J:229255
	absent pinna reflex	J:229255
	calcinosis	J:229255
	decreased body size	J:229255
	decreased femur compact bone thickness	J:229255
	hunched posture	J:229255
	impaired hearing	J:229255
	kyphoscoliosis	J:229255
	postnatal growth retardation	J:229255
	premature death	J:229255
	short femur	J:229255
	thick zygomatic arch	J:229255
	wide ribs	J:229255
Klem1Btlr/Klem1Btlr C57BL/6J-Klem1Btlr/Btlr	short femur	J:309727
	short tibia	J:309727
	small pubis	J:309727
Klkl/Kl+ involves: C3H/HeJ * C57BL/6J	abnormal blood vessel physiology	J:76383
	alopecia	J:59775
	calcified pulmonary alveolus	J:59775
	decreased circulating insulin level	J:64878
	decreased insulin secretion	J:64878
	emphysema	J:59775
	hypoglycemia	J:64878
	kyphosis	J:59775
Klkl/Klkl either: C.Cg-Klkl or (involves: C3H/HeJ * C57BL/6J)	abnormal adenohypophysis morphology	J:44109
	abnormal blood circulation	J:44109
	abnormal bone ossification	J:44109
	abnormal bone structure	J:44109
	abnormal circulating mineral level	J:44109
	abnormal gametogenesis	J:44109
	abnormal gonadotroph morphology	J:44109
	abnormal leukocyte cell number	J:44109
	abnormal seminiferous tubule morphology	J:44109
	abnormal skin condition	J:44109
	absent mature ovarian follicles	J:44109
	arrest of male meiosis	J:44109
	arteriosclerosis	J:44109
	azoospermia	J:44109
	calcified aorta	J:44109
	calcified artery	J:44109
	calcified muscle	J:44109
	calcified pulmonary alveolus	J:44109
	calcified skin	J:44109
	calcinosis	J:44109
	decreased bone mineral density	J:44109
	decreased compact bone thickness	J:44109
	decreased hair follicle number	J:44109
	decreased insulin secretion	J:44109
	decreased locomotor activity	J:44109
	decreased osteoclast cell number	J:44109
	decreased Purkinje cell number	J:44109
	decreased somatotroph cell size	J:44109
	decreased somatotroph secretory granule number	J:44109
	decreased subcutaneous adipose tissue amount	J:44109
	emphysema	J:44109
	external male genitalia atrophy	J:44109
	hypoglycemia	J:44109
	increased circulating calcium level	J:44109
	infertility	J:44109
	kyphosis	J:44109
	osteoporosis	J:44109
	ovary atrophy	J:44109
	postnatal growth retardation	J:44109
	premature aging	J:44109
	premature death	J:44109
	Purkinje cell degeneration	J:44109
	short stride length	J:44109
	sparse hair	J:44109
	testicular atrophy	J:44109
	thin epidermis	J:44109
	thymus atrophy	J:44109
	uterus atrophy	J:44109
	vulva atrophy	J:44109
Klkl/Klkl involves: 129S1/SvImJ * C3H/HeJ * C57BL/6J	abnormal retina morphology	J:214493
	decreased a-wave amplitude	J:214493
	decreased b-wave amplitude	J:214493
	increased a-wave latency	J:214493
	increased b-wave latency	J:214493
Klkl/Klkl involves: C3H/HeJ * C57BL/6J	abnormal contextual conditioning behavior	J:81240
	abnormal cued conditioning behavior	J:81240
	abnormal nervous system physiology	J:81240
	decreased B cell number	J:80503
	decreased body weight	J:80503
	decreased circulating insulin level	J:64878
	decreased insulin secretion	J:64878
	decreased osteoclast cell number	J:80503
	hypoglycemia	J:64878
	impaired long-term object recognition memory	J:81240
	increased insulin sensitivity	J:64878
	osteopetrosis	J:80503
	oxidative stress	J:81240
	postnatal growth retardation	J:81240
	premature death	J:81240
	short femur	J:80503
Klkl/Klkl involves: C3H/J * C57BL/6J	abnormal bone mineral density	J:56666
	abnormal cardiovascular system physiology	J:102218
	abnormal glucose homeostasis	J:66078
	abnormal heart valve morphology	J:102218
	abnormal liver physiology	J:66078
	abnormal lung morphology	J:59775
	abnormal osteoblast morphology	J:56666
	abnormal osteoblast physiology	J:56666
	abnormal osteoclast morphology	J:56666
	abnormal pancreatic beta cell morphology	J:66078
	abnormal pulmonary alveolus morphology	J:59775
	abnormal pulmonary interalveolar septum morphology	J:59775
	abnormal respiratory mechanics	J:59775
	abnormal sinoatrial node conduction	J:102218
	abnormal trabecular bone morphology	J:56666
	arteriosclerosis	J:102218
	calcified aortic valve annulus	J:102218
	calcified mitral valve annulus	J:102218
	decreased body length	J:59775
	decreased body temperature	J:66078
	decreased bone mineral density	J:56666
	decreased bone mineral density of femur	J:56666
	decreased bone ossification	J:56666
	decreased bone resorption	J:56666
	decreased brown fat cell lipid droplet size	J:66078
	decreased circulating insulin level	J:66078
	decreased compact bone thickness	J:56666
	decreased femur compact bone thickness	J:56666
	decreased heart rate	J:102218
	decreased liver weight	J:66078
	decreased osteoblast cell number	J:56666
	decreased tidal volume	J:59775
	decreased white adipose tissue amount	J:66078
	dilated pulmonary alveolar duct	J:59775
	emphysema	J:59775
	hypoglycemia	J:66078
	improved glucose tolerance	J:66078
	increased brown adipose tissue amount	J:66078
	increased circulating noradrenaline level	J:102218
	increased insulin sensitivity	J:66078
	increased lung compliance	J:59775
	increased susceptibility to induced morbidity/mortality	J:102218
	postnatal growth retardation	J:66078
	prolonged RR interval	J:102218
	small pancreatic islets	J:66078
Klm1Anu/Klm1Anu C57BL/6NCrlAnu-Klm1Anu	abnormal autopod morphology	J:104190
	abnormal definitive hematopoiesis	J:104190
	abnormal duodenum morphology	J:104190
	abnormal heart morphology	J:104190
	abnormal kidney collecting duct morphology	J:104190
	abnormal kidney cortex morphology	J:104190
	abnormal kidney medulla morphology	J:104190
	abnormal kidney morphology	J:104190
	abnormal smooth muscle morphology	J:104190
	abnormal spleen morphology	J:104190
	abnormal stomach morphology	J:104190
	abnormal tracheal cartilage morphology	J:104190
	absent bone trabeculae	J:104190
	dehydration	J:104190
	diaphragmatic hernia	J:104190
	dilated gastric gland	J:104190
	hemorrhage	J:104190
	increased circulating calcium level	J:104190
	respiratory distress	J:104190
	small spleen	J:104190
Kltm1.1Tel/Kltm1.1Tel Tg(Cdh16-cre)91Igr/0 involves: C57BL/6 * ICR	decreased circulating parathyroid hormone level	J:201719
	normal homeostasis/metabolism phenotype	J:201719
	increased circulating parathyroid hormone level	J:201719
	increased circulating phosphate level	J:201719
	increased urine calcium level	J:201719
Kltm1.2Tel/Kltm1.2Tel involves: C57BL/6 * FVB/N	abnormal kidney morphology	J:201719
	decreased body size	J:201719
	decreased locomotor activity	J:201719
	increased circulating calcium level	J:201719
	increased circulating phosphate level	J:201719
	kidney cortex hypoplasia	J:201719
	kyphosis	J:201719
	nephrocalcinosis	J:201719
	postnatal growth retardation	J:201719
	premature death	J:201719
	renal fibrosis	J:201719
	small kidney	J:201719
Kltm1Lex/Kltm1Lex B6.129S-Kltm1Lex	decreased body size	J:173962
	increased circulating calcium level	J:173962
	increased circulating phosphate level	J:173962
Kltm1Lex/Kltm1Lex involves: 129S5/SvEvBrd * C57BL/6J	abnormal femur morphology	J:103485
	abnormal trabecular bone morphology	J:103485
	decreased body length	J:103485
	decreased body weight	J:103485
	premature death	J:103485
Kltm1Yin/Kltm1Yin Not Specified	abnormal long bone epiphysis morphology	J:86859
	abnormal vitamin D level	J:86859
	decreased body weight	J:86859
	decreased bone mineral density	J:86859
	decreased white adipose tissue amount	J:86859
	increased circulating calcium level	J:86859
	increased circulating phosphate level	J:86859
	postnatal growth retardation	J:86859
	premature death	J:86859
Kltm2Yin/Kltm2Yin involves: 129S/SvEv	decreased heart rate	J:102218
	increased susceptibility to induced morbidity/mortality	J:102218
	premature aging	J:102218
	premature death	J:102218